… treatment of diabetic patients, type 2 diabetes represents in 2007 a major threat for Public
Health in France, due to its impact on the diabetic individuals with the development of diabetes-…

… physical and psychological detriment to patients. As of 2019, 463 million people are
estimated to be living with DM worldwide, out of which 90% have type-2 diabetes mellitus (T2DM). …

… This review explores the current conventional drugs used in the treatment of type 2 DM, the
associated limitations related to their usage and the cutting edge novel nanoformulations that …

… of anti-diabetic medications. In the future, new perspectives and scientific investigations will
be introduced for changing the landscape of current anti-diabetic therapeutics if possible. A …

… treatment of this syndrome, the harmful macrovascular and microvascular outcomes of type
2 diabetes … aspects of the pathogenesis and treatment of type 2 diabetes, and discuss future …

… (WHO) the number of adults living with diabetes is expected to increase. Since type 2 diabetes
mellitus (T2DM) is suffered by the majority of diabetic patients (around 90–95%) and often …

… for type 2 diabetes. Emerging views on therapeutic strategies for type 2 diabetes are also
discussed. … Another new class of diabetes therapeutics is the GLP-1 analogues (exenatide and …

… The development of novel therapeutics using various methods, such as novel medication
combinations, changed drug molecules, and enhanced delivery systems, can eliminate some …

… therapeutics possibilities, especially in the T2DM, the interventions in the life style are
essentials in the approach of these patients and they are needed to get the therapeutics goals[13]. …

… GLP-1 levels are lower than normal in T2DM [53], and this understanding contributed to the
development of therapeutical strategies aiming at increasing GLP-1 levels in order to reduce …